Unknown

Dataset Information

0

Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3.


ABSTRACT: Inflammatory bowel diseases (IBDs) are increasingly common diseases characterized by chronic and relapsing inflammation of the gastrointestinal tract. NLRP3 might be a crucial regulator of the homeostatic balance of the intestine, but its upregulation leads to pyroptosis. Munronoid I is extracted and purified from Munronia sinica, which has shown an anti-inflammatory effect, but the efficacy of Munronoid I in IBD remains unproven. In this study, we attempted to determine the effect of Munronoid I on NLRP3 to regulate the inflammasome activation and pyroptosis in IBD. Our data demonstrated that Munronoid I treatment attenuated DSS-induced body weight loss, pathological injury of the colon, the production of IL-1β and IL-18, and the expression of pyroptosis-associated proteins in colon tissue in mice. Moreover, Munronoid I inhibited LPS/ATP-induced pyroptosis in mouse peritoneal macrophages, MODE-K cells, and DSS-induced pyroptosis in mouse colonic epithelial cells, and decreased the release of inflammatory cytokines IL-1β and IL-18 in mouse peritoneal macrophages. Mechanically, Munronoid I could suppress the NLRP3 inflammasome activation and pyroptosis by promoting the K48-linked ubiquitination and NLRP3 degradation. It is suggested that Munronoid I might be a potential therapeutic candidate for IBD.

SUBMITTER: Ma X 

PROVIDER: S-EPMC9296101 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis <i>Via</i> Modulation of NLRP3.

Ma Xingyu X   Di Qianqian Q   Li Xiaoli X   Zhao Xibao X   Zhang Ruihan R   Xiao Yue Y   Li Xunwei X   Wu Han H   Tang Haimei H   Quan Jiazheng J   Wu Zherui Z   Xiao Weilie W   Chen Weilin W  

Frontiers in immunology 20220705


Inflammatory bowel diseases (IBDs) are increasingly common diseases characterized by chronic and relapsing inflammation of the gastrointestinal tract. NLRP3 might be a crucial regulator of the homeostatic balance of the intestine, but its upregulation leads to pyroptosis. Munronoid I is extracted and purified from <i>Munronia sinica</i>, which has shown an anti-inflammatory effect, but the efficacy of Munronoid I in IBD remains unproven. In this study, we attempted to determine the effect of Mun  ...[more]

Similar Datasets

| S-EPMC5017608 | biostudies-literature
| S-EPMC10507139 | biostudies-literature
| S-EPMC9920828 | biostudies-literature
| S-EPMC7453595 | biostudies-literature
| S-EPMC9525652 | biostudies-literature
| S-EPMC5124666 | biostudies-literature
| S-EPMC8754606 | biostudies-literature
| S-EPMC10768115 | biostudies-literature
| S-EPMC11395497 | biostudies-literature
| S-EPMC10629261 | biostudies-literature